Scientists at the Oxford Parkinson's Disease Centre (OPDC) have been able to use a highly-sensitive method called α-synuclein real-time quaking-induced conversion (αSyn-RT-QuIC) to observe the clumping of alpha-synuclein ...
Dec 15, 2021
0
73
A subtle smile emerged on Dr. James Leidner's face as he envisioned telling people of the unusual contribution he made to mankind's mission to Mars.
Dec 9, 2021
0
111
In an unexpected discovery, Georgetown University Medical Center researchers have identified what appears to be a significant vascular defect in patients with moderately severe Parkinson's disease. The finding could help ...
Nov 12, 2021
0
389
Monoclonal antibodies protected aged, diabetic rhesus macaque monkeys from disease due to SARS-CoV-2 and reduced signs of inflammation, including in cerebrospinal fluid, according to a new study from researchers at the University ...
Nov 1, 2021
0
94
Suicidal thoughts, "paranoia-like fears," delusions and "foggy brain" have been identified in three adolescents who had mild or asymptomatic COVID-19. Now, a new study into their immune responses identifies a potential mechanism ...
Oct 25, 2021
1
485
Scientists at St. Jude Children's Research Hospital have shown that cell-free DNA from cerebrospinal fluid (CSF) can be used to detect measurable residual disease (MRD) in children treated for the brain tumor medulloblastoma. ...
Oct 21, 2021
0
46
T-cells respond to buildups of alpha-synuclein, the aggregated protein clumps that are a feature of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease (PD), according to a Northwestern ...
Oct 15, 2021
0
90
Researchers at Karolinska Institutet in Sweden have compared how well different Alzheimer's biomarkers predict the progression of the disease and its effect on the memory. They found that early accumulation of tau proteins ...
Sep 30, 2021
1
79
A team of researchers at The Hong Kong Polytechnic University has developed what they describe as a fast and inexpensive way to test for SARS-CoV-2 antibodies in human patients. The results are published in the journal Science ...
Testing for some inflammatory proteins associated with the nervous and immune systems will help diagnose the earlier onset and progression of Alzheimer's disease, according to a Rutgers study.
Aug 26, 2021
0
297
